Latest stories on OKUR
OnKure Therapeutics, Inc. (OKUR) files 8-K
SEC 8-K50 · neutralgeneral
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
StockTitan42 · neutralearnings
H.C. Wainwright cuts OnKure stock price target to $21 on valuation changes
Investing.com Analyst Ratings38 · neutralanalyst